Royalty Pharma plc RPRX | NASDAQ
Next Earnings: Apr 05, 2026
Company Overview:
5.8 Year RPRX Performance Metrics:
RPRX Dividend Payments, Yield & Share Price charts
Unlock All Reports & Research Dividend Stocks like a BOSS!
Get 3 months FREE!
RPRX Dividend Safety: Payout & Dividend to Free Cash Flow Ratios.
RPRX Earnings, Revenue, Cash & Debt, Shares Outstaning:
Revenue, EPS, Net Income & Ebitda - Estimates VS Actual:
Ratios, Profit Margins & Return on Capital:
RPRX Dividends Info:
RPRX Dividend History: Dates, Payments & Yield list
Below is a schedule of all RPRX dividend payments, ex-dates, share price on the day of the payment as well as TTM & forward yield
| Ex-Date | Payment Date | Amount | TTM Yield | Forward Yield | Price on Ex-Date |
|---|---|---|---|---|---|
| 02/20/2026 | 03/10/2026 | $0.235 | 1.98% | 2.04% | $45.97 |
| 11/14/2025 | 12/10/2025 | $0.220 | 2.25% | 2.3% | $38.26 |
| 08/15/2025 | 09/10/2025 | $0.220 | 2.39% | 2.43% | $36.18 |
| 05/16/2025 | 06/10/2025 | $0.220 | 2.53% | 2.62% | $33.58 |
| 02/20/2025 | 03/10/2025 | $0.220 | 2.78% | 2.69% | $32.75 |
| 02/21/2025 | 03/10/2025 | $0.220 | 2.54% | 2.69% | $32.75 |
| 11/15/2024 | 12/10/2024 | $0.210 | 3.27% | 3.28% | $25.59 |
| 08/16/2024 | 09/13/2024 | $0.210 | 3.05% | 3.03% | $27.72 |
| 05/16/2024 | 06/14/2024 | $0.210 | 2.94% | 3.12% | $26.92 |
| 02/15/2024 | 03/15/2024 | $0.210 | 2.7% | 2.79% | $30.09 |
| 11/16/2023 | 12/15/2023 | $0.200 | 3.02% | 2.92% | $27.37 |
| 08/17/2023 | 09/15/2023 | $0.200 | 2.7% | 2.84% | $28.13 |
| 05/18/2023 | 06/15/2023 | $0.200 | 2.32% | 2.48% | $32.20 |
| 02/15/2023 | 03/15/2023 | $0.200 | 2.04% | 2.32% | $34.50 |
| 11/17/2022 | 12/15/2022 | $0.190 | 1.8% | 1.86% | $40.79 |
| 08/18/2022 | 09/15/2022 | $0.190 | 1.68% | 1.8% | $42.17 |
| 05/19/2022 | 06/15/2022 | $0.190 | 1.81% | 1.97% | $38.53 |
| 02/17/2022 | 03/15/2022 | $0.190 | 1.76% | 1.99% | $38.27 |
| 11/18/2021 | 12/15/2021 | $0.170 | 1.62% | 1.81% | $37.52 |
| 08/19/2021 | 09/15/2021 | $0.170 | 1.7% | 1.79% | $37.97 |
| 05/19/2021 | 06/15/2021 | $0.170 | 1.6% | 1.54% | $44.02 |
| 02/18/2021 | 03/15/2021 | $0.170 | 1.01% | 1.45% | $46.84 |
| 11/19/2020 | 12/15/2020 | $0.150 | 0.72% | 1.37% | $43.85 |
| 09/14/2020 | 09/30/2020 | $0.150 | 0.38% | 1.43% | $42.07 |
Projected Future Returns & Dividends for RPRX
Based on past 5.8-year performance, here are RPRX growth metrics:
Share price CAGR of +1.52%
Dividend CAGR of +8.6%
Using RPRX CAGR metrics, we can estimate that your initial $10000 investment, over the next 10 years, should grow as follows:
| RPRX (DRIP) | RPRX - No DRIP | |
|---|---|---|
| Current Price | $48.57 | $48.57 |
| Start Shares | 205.89 | 205.89 |
| Start Value | $10,000 | $10,000 |
| After 10 years: | ||
| Final Share Count | 268.68 | 205.89 |
| Dividends Payment | $0.54 | $0.54 |
| Annual Dividends | $576 | $442 |
| Yield on cost | 5.76% | 4.42% |
| Share Price | $55.63 | $55.63 |
| Total Dividends | $3,305 | $2,885 |
| Final Value | $14,948 | $14,340 |
NOTE: Above numbers are our estimate based on RPRX's Dividend and Price CAGR over past 5.8 years.
These numbers should only be considered as "potential future returns"! DRIP assumes reinvesting dividends; No-DRIP assumes collecting dividends as cash.
We cannot guarantee that your actual returns will meet these estimates.
Get the best Dividend Stock Research Tools:
Get 3 months FREE!
Company Info
Royalty Pharma plc (RPRX) had its IPO on 2020-06-16, and is trader on NASDAQ stock exchange.
Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovations in the biopharmaceutical industry in the United States. It is also involved in the identification, evaluation, and acquisition of royalties on various biopharmaceutical therapies. In addition, the company collaborates with innovators from academic institutions, research hospitals and not-for-profits, small and mid-cap biotechnology companies, and pharmaceutical companies. Its portfolio consists of royalties on approximately 35 marketed therapies and 10 development-stage product candidates that address various therapeutic areas, such as rare disease, cancer, neurology, infectious disease, hematology, and diabetes. The company was founded in 1996 and is based in New York, New York.
RPRX website: https://www.royaltypharma.com
Get Full Access to All Reports with DRIPCalc PRO
Get 3 months FREE!
